AI in Drug Discovery Strategic Intelligence Research Report 2024: Healthcare, Macroeconomic, Technology, and Regulatory Trends Impacts
20. Dezember 2024 09:49 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: AI in drug discovery" report has been added to ResearchAndMarkets.com's offering. This report consolidates the latest...
China Pioneers Innovative Drug Development with a Surge in CAR-T Cell and ADC Therapy Advancements
20. Dezember 2024 09:26 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Drug Development Trends in China" report has been added to ResearchAndMarkets.com's offering.China has emerged as a critical player in global drug...
Biopreservation Market to Accelerate at 18.2% CAGR, Reaching Revenues of US$24.5 Billion by 2033
20. Dezember 2024 06:43 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Biopreservation Market: Global Forecast by Product, Application, Countries and Company Analysis" report has been added to ResearchAndMarkets.com's...
AI Driven Drug Discovery Patent Landscape Report 2024: Comprehensive Patent Landscape for AI-driven Drug Discovery, Analyzing 1,087 Patents from 2002 to 2024
16. Dezember 2024 12:27 ET
|
Research and Markets
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "AI Driven Drug Discovery Patent Landscape Report 2024" report has been added to ResearchAndMarkets.com's offering. The report provides a...
Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development
16. Dezember 2024 06:00 ET
|
Brains Bioceutical Corp
Brains Bioceutical expands its cannabinoid API portfolio with new D9-THC, CBN, and CBG offerings, driving innovation in drug development and research
Precede Biosciences Presents a Novel ER Transcriptional Dependency Index at SABCS 2024 Designed to Further Inform Use of Endocrine Therapy from a Simple Blood Test
12. Dezember 2024 08:00 ET
|
Precede Biosciences, Inc.
Precede Bio’s ER dependency index (PERDI) tests for both ER dependent and ER independent mechanisms of cancer growth, addressing an important unmet need in the field todayThere are approximately...
IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights
05. Dezember 2024 08:00 ET
|
Biognosys AG
IonOpticks and Biognosys announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns.
Certara Showcases 2024 Research Wins With Over 100 Papers Published
02. Dezember 2024 16:15 ET
|
Certara
RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100...
Oligonucleotides Market Outlook 2034: Projected to Reach US$ 13.1 Billion by 2034, Driven by Expanding Applications in Biotechnology and Precision Medicine | TMR
02. Dezember 2024 10:08 ET
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc.:, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global oligonucleotides market (mercado de oligonucleótidos) is poised for significant growth,...
FDA (Food and Drug Administration) Drug Approval Process Training Course: Comprehensive Programme Covering Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (LIVE ONLINE EVENT/ON-DEMAND)
21. November 2024 06:08 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" conference has been added to ResearchAndMarkets.com's offering. The US...